Reports for HYDROCHLOROTHIAZIDE

Ingredient

HYDROCHLOROTHIAZIDE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-HYDROCHLOROTHIAZIDE 12.5MG TABLET Resolved 2024-03-22 2024-04-26 223083
APO TRIAZIDE 25MG 50MG TABLET Resolved 2024-03-08 2024-04-05 221702
CANDESARTAN/HCTZ 12.5MG 16MG TABLET Resolved 2024-02-26 2024-03-09 220663
ACH-OLMESARTAN HCTZ 20MG 12.5MG TABLET Actual shortage 2024-02-16 2024-02-17 219792
PMS-IRBESARTAN-HCTZ 25MG 300MG TABLET Actual shortage 2024-02-07 2024-04-29 218776
JAMP CANDESARTAN-HCT 12.5MG 16MG TABLET Actual shortage 2024-02-07 2024-04-17 218700
SANDOZ LISINOPRIL HCT 25MG 20MG TABLET Actual shortage 2024-02-05 2024-02-06 218465
IRBESARTAN/HCTZ 25MG 300MG TABLET Resolved 2024-01-30 2024-03-17 217829
APO-OLMESARTAN/HCTZ 12.5MG 40MG TABLET Anticipated shortage 2024-01-19 2024-01-19 216723
APO-OLMESARTAN/HCTZ 12.5MG 20MG TABLET Anticipated shortage 2024-01-19 2024-01-19 216720

Showing 11 to 20 of 671

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-LISINOPRIL/HCTZ 12.5MG 10MG TABLET Discontinued 2017-03-13 2017-03-13 1093
APO-LISINOPRIL/HCTZ 12.5MG 20MG TABLET Discontinued 2017-03-13 2017-03-13 1090

Showing 101 to 102 of 102